Glaucoma is the largest cause of permanent blindness globally. Primary open-angle glaucoma (POAG) is one of chronic glaucoma and is asymptomatic in the early stage. This study was performed to identify the clinical characteristics and management of POAG patients at the Cicendo Eye Hospital, Bandung, Indonesia. This retrospective, descriptive study was conducted on medical records of POAG patients in Cicendo Eye Hospital in January-December 2020 using whole sampling method. Sociodemographic, clinical characteristics, and management data were collected. From 147 subjects obtained, the largest age group of POAG patients was 60-69 years old (30.6%), with most of the patients being male (68.0%). Most of the patients experienced blindness (37.6%) and had cup-to-disc ratio (CDR) 0.9-1.0 (36.8%). The mean of pre-treatment IOP was 29.1±13.1 mmHg, and the mean of post-treatment was 19.3±7.7 mmHg. The mean of anti-glaucoma medication in the first and the last control were 1.93±0.59 and 1.48±0.70, respectively. The most common treatments were medication only (69.8%), with combined surgery as the most performed surgery. In conclusion, most POAG patients were 60 years old or older and male, with most eyes being blind. The POAG treatments were mostly anti-glaucoma medication only to lower IOP as the goals of the treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.